speb/financial-data huggingface dataset:
Financial scorecard for NXT.MC (Consumer Cyclical — Apparel Manufacturing, Spain)
Report date: 2025-12-31 (annual)
Stock price: 1.2183908045977012
Market cap: 456110976 (USD: 536601148.2352941)
P/E ratio: 108.23529411764707
P/B ratio: 31.18805240368707
Debt to equity: 2.0244
Current ratio: 0.75
Interest coverage ratio: 1.7733333333333334
Return on net tangible assets (%): -19.380195157209986
Buffett classification: The Gruesome
Rule of 40 score: -0.8772123872483064
Piotroski F-score: 2 (Weak)
Magic formula: return on capital % 51.50501672240804, earnings yield % 1.4247895770832255, rank 1577
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 3.9565800392695074
Total shareholder yield (%): 3.9565800392695074 (Low Return)
Momentum (%): 1m 9.278350515463915, 3m 23.272481406355656, 6m 12.668396984303538, 12m 130.14048531289913, composite 48.847044606166946 (Strong Uptrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 4, short score 8, recommendation: Short
Revenue growth 1y (%): 42.967677524023465
Net income growth 1y (%): 38.24208667300639
Revenue CAGR 3y (%): -11.906162895764282
Revenue deceleration: no
Revenue growth consistency score: 43.76314079458393
Beneish M-score: -2.437463028210559 (Likely Safe)
ROE (%): 116.88529055590742
Net margin (%): 12.191915872494251
Asset turnover: 0.5755984241030657
Equity multiplier (leverage): 16.655907767739052
ROE archetype: Leverage-Driven Returns
P/E z-score: 4.031619391039375
Treasury beta 1y: -0.08653409281636765 (R-squared: 0.0047802390698658105)
Dividend increase streak (years): 0
ROIC (%): 19.96793346477213 (pretax: 26.388888888888886)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 63.05732484076433, P/B 77.70700636942675, ROIC 7.643312101910828, revenue growth 1y 5.095541401273886, 6m momentum 22.929936305732486
Sector percentiles: P/E 63.00417246175244, 6m momentum 17.837273991655074
Industry median P/E: 0.8420334714862808; industry median ROIC: 4.712308174264459
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.09098350834986599
Base cash flow: 2523529.4117647074
DCF price per share: base 0.061830458261981636, conservative 0.05236151278729882, aggressive 0.07312560554754338
Financial scorecard for NYKAA.NS (Consumer Cyclical — Internet Retail, India)
Report date: 2026-03-31 (annual)
Stock price: 3.33195706028076
Market cap: 924462874624 (USD: 9797190277.914371)
P/E ratio: 3.4921493510546293
P/B ratio: 44.606303475849714
Debt to equity: 0.8240999999999999
Current ratio: 1.16
Interest coverage ratio: 3.6883538251366117
Return on net tangible assets (%): 31.26390089553241
Buffett classification: The Good
Analyst consensus upside (%): 12319.003234042555
Rule of 40 score: 19.01278086439777
Altman Z-score: 18.625028351654844 (Safe Zone)
Piotroski F-score: 3 (Weak)
Magic formula: return on capital % 11.545056518337248, earnings yield % 0.0015523387450299079, rank 1959
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.23683545010261225
Total shareholder yield (%): 0.23683545010261225 (Low Return)
Momentum (%): 1m 3.4700401296974785, 3m 19.32359638609624, 6m 29.984656343973764, 12m 33.51316668595569, composite 26.11461099970076 (Strong Uptrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 5, short score 4, recommendation: Neutral
Revenue growth 1y (%): 14.286144895787611
Net income growth 1y (%): 156.5247107679272
Revenue CAGR 3y (%): 19.441725994397686
Net income CAGR 3y (%): 103.80517809491732
Revenue deceleration: yes
Revenue growth consistency score: 4.516860661266346
Accrual ratio: -0.06365568845921976
FCF conversion rate: 2.4047759144846523
Beneish M-score: -2.725628371607562 (Likely Safe)
ROE (%): 13.67256082085044
Net margin (%): 2.034852105544109
Asset turnover: 2.22688257610828
Equity multiplier (leverage): 3.0173083655770783
ROE archetype: Standard Business
P/E z-score: 4.677677100209699
FCF z-score: 2.853092846558612
Treasury beta 1y: -6.363863606154842e-05 (R-squared: 8.553831591049729e-07)
Dividend increase streak (years): 0
ROIC (%): 13.322404786418865 (pretax: 20.496007363721333)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 27.81456953642384, P/B 64.90066225165563, ROIC 25.165562913907287, revenue growth 1y 22.516556291390728, 6m momentum 5.960264900662252
Sector percentiles: P/E 40.78581363004172, 6m momentum 8.657858136300417
Industry median P/E: 2.072622107969152; industry median ROIC: 4.884758827297602
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.06724918450944163
Base cash flow: 39476473.08181433
DCF price per share: base 0.006881721311904694, conservative 0.003532642233389929, aggressive 0.013358964398364455
Financial scorecard for NZM2.DE (Basic Materials — Specialty Chemicals, Denmark)
Report date: 2026-03-31 (quarterly)
Stock price: 62.75
Market cap: 25745141760 (USD: 3948641374.233129)
P/E ratio: 45.959051724137936
P/B ratio: 14.488720017965292
Debt to equity: 0.2942
Current ratio: 1.67
Return on net tangible assets (%): -54.694621695533286
Buffett classification: The Good
Rule of 40 score: 16.16701595728148
Altman Z-score: 3.8784552424306877 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Magic formula: return on capital % 7.046538610287481, earnings yield % 0.1473194991298197, rank 1617
Dividend yield (%): 1.0297088377733603
Buyback yield (%): 0
Total shareholder yield (%): 1.0297088377733603 (Low Return)
Momentum (%): 1m -0.03620564808110168, 3m 5.4003906249999885, 6m 8.277507105156314, 12m , composite 6.838948865078152 (Flat)
Lynch category: Cyclical (confidence: High)
Screener: long score 8, short score 3, recommendation: Long
Revenue growth 1y (%): 9.764157227376447
Net income growth 1y (%): 13.117537436506366
Revenue deceleration: no
Revenue growth consistency score: 3.335955478821532
Accrual ratio: 0.007517193526662722
FCF conversion rate: 0.37167252636865894
Beneish M-score: -2.409385455963947 (Likely Safe)
ROE (%): 1.806068779962654
Net margin (%): 17.78790315375681
Asset turnover: 0.06725815119419333
Equity multiplier (leverage): 1.50960944359533
ROE archetype: Low Return
P/E z-score: 2.1573095419403696
FCF z-score: 2.1573095419403696
Treasury beta 1y: -0.037667369530999716 (R-squared: 0.0012882065387687521)
Dividend increase streak (years): 0
ROIC (%): 6.561591392488299 (pretax: 8.35827114663434)
Incremental ROIC 3y (%): 3.1315601873023824 (pretax: 4.193320552475404)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 64.88372093023256, P/B 75.5813953488372, ROIC 39.06976744186046, revenue growth 1y 15.813953488372093, 6m momentum 36.04651162790697
Sector percentiles: P/E 34.203220433092724, 6m momentum 16.102165463631316
Industry median P/E: 0.2375559102197765; industry median ROIC: 5.779832452013451
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.081
Base cash flow: 120801886.79245283
DCF price per share: base 2.2399603811649493, conservative 1.2387434893692244, aggressive 4.085992789077076
Financial scorecard for OHLA.MC (Industrials — Engineering & Construction, Spain)
Report date: 2025-12-31 (annual)
Stock price: 0.5402298850574713
Market cap: 645603200 (USD: 759533176.4705882)
P/E ratio: 42.19783463116839
P/B ratio: 0.7952962164718965
Debt to equity: 0.6618
Current ratio: 1.3
Interest coverage ratio: 2.355270178279028
Return on net tangible assets (%): 13.596581154354457
Buffett classification: The Good
Analyst consensus upside (%): 34.58333333333332
Rule of 40 score: 6.933044553435106
Piotroski F-score: 8 (Strong)
Magic formula: return on capital % 15.952467588138825, earnings yield % 24.080945783253938, rank 1183
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -13.330014473286376
Total shareholder yield (%): -13.330014473286376 (Minimal or Negative)
Momentum (%): 1m 6.8181818181818095, 3m -5.184142622566268, 6m 25.566946256601437, 12m 43.49856321839081, composite 18.240628031268432 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 9, short score 3, recommendation: Long
Revenue growth 1y (%): 6.857128737505058
Revenue CAGR 3y (%): 10.068802872993698
Revenue deceleration: yes
Revenue growth consistency score: 3.70641484874306
Accrual ratio: 0.002765501958759011
FCF conversion rate: 0.22240122095981005
Beneish M-score: -2.150398522464081 (Likely Safe)
Equity multiplier (leverage): 5.6964376319314045
ROE archetype: Standard Business
P/E z-score: 3.888928667756556
FCF z-score: 5.071253035332674
Treasury beta 1y: -0.15250538954395965 (R-squared: 0.010462435294596853)
Dividend increase streak (years): 0
ROIC (%): 20.190916193905622 (pretax: 31.06294799062403)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 68.39378238341969, P/B 24.352331606217618, ROIC 15.716753022452504, revenue growth 1y 23.316062176165804, 6m momentum 17.616580310880828
Sector percentiles: P/E 62.54480286738351, 6m momentum 14.311315924219151
Industry median P/E: 0.3073205413493449; industry median ROIC: 8.170542376375224
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.09484022443367846
Base cash flow: 64754117.647058815
DCF price per share: base 1.3892696732626286, conservative 0.978904922010049, aggressive 2.0324357472883614
Financial scorecard for OTEX.TO (Technology — Software - Application, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 22.382978723404257
Market cap: 7658424320 (USD: 5509657784.172662)
P/E ratio: 7.601091540560656
P/B ratio: 1.8756146587634555
Debt to equity: 1.6183
Current ratio: 0.94
Interest coverage ratio: 3.224107823029593
Return on net tangible assets (%): -5.379918830302275
Buffett classification: The Great
Analyst consensus upside (%): 44.761422976501294
Rule of 40 score: 17.497065712959092
Altman Z-score: 0.8460364246134936 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Magic formula: return on capital % 72.63037836325087, earnings yield % 1.5441931513177793, rank 229
Dividend yield (%): 0.8648384737188342
Buyback yield (%): 3.2418940192647883
Debt paydown yield (%): 3.595078674904786
Total shareholder yield (%): 7.701811167888408 (Moderate Return)
Momentum (%): 1m 5.2793301995165365, 3m 1.3038680246575276, 6m -20.060790273556236, 12m -23.18735537766897, composite -15.265373109643752 (Strong Downtrend)
Lynch category: Fast Grower (confidence: Medium)
Screener: long score 6, short score 7, recommendation: Neutral
Revenue growth 1y (%): 5.185707002522988
Net income growth 1y (%): 91.40188828969995
Revenue deceleration: no
Accrual ratio: -0.009752940437030573
FCF conversion rate: 1.7647913494989957
Beneish M-score: -2.5606048526398077 (Likely Safe)
ROE (%): 4.282117698606
Net margin (%): 13.469977481551714
Asset turnover: 0.09467291191533043
Equity multiplier (leverage): 3.3578863672702965
ROE archetype: Low Return
P/E z-score: 4.997264483495424
FCF z-score: 4.997264483495424
Treasury beta 1y: 0.007015902228559754 (R-squared: 0.0065538951411137575)
Dividend increase streak (years): 0
ROIC (%): 9.975341872895259 (pretax: 11.02774128688889)
Incremental ROIC 3y (%): 17.13731530617362 (pretax: 13.932780959483168)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E 32.21024258760108, P/B 27.22371967654987, ROIC 33.692722371967655, revenue growth 1y 38.94878706199461, 6m momentum 50.943396226415096
Sector percentiles: P/E 32.932932932932935, 6m momentum 54.88822155488822
Industry median P/E: 2.1394954536591486; industry median ROIC: 6.21806735836372
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.08674081406161563
Base cash flow: 681816058.3941605
DCF price per share: base 77.51747712315155, conservative 40.829662265297685, aggressive 139.34679939935864
Financial scorecard for PAVS (Consumer Defensive — Packaged Foods, United States)
Report date: 2025-09-30 (quarterly)
Stock price: 4.17
Market cap: 4168159 (USD: 4168159)
P/B ratio: 3760.2219696536545
Debt to equity: 0.10830000000000001
Current ratio: 1.15
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -17.474693263860615
Total shareholder yield (%): -17.474693263860615 (Minimal or Negative)
Momentum (%): 1m -68.88059701492537, 3m -97.14383561643837, 6m -99.80801104972376, 12m -99.9963536201469, composite -98.98004309415383 (Strong Downtrend)
Lynch category:  (confidence: Low)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.6072122676850955 (Likely Safe)
Equity multiplier (leverage): 1.2683841123527642
ROE archetype: Standard Business
Treasury beta 1y: 0.012763078978806955 (R-squared: 0.0005689594558310111)
Dividend increase streak (years): 0
ROIC (%): -6.8969427508502035 (pretax: -8.730307279557218)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 70.96018735362998, ROIC 69.3208430913349, revenue growth 1y , 6m momentum 83.37236533957847
Sector percentiles: P/E , 6m momentum 84.35916002896452
Industry median P/E: 0.5444598070416563; industry median ROIC: 6.765322712696236
Sector median P/E: 1.0302878025850322; sector median ROIC: 7.163828537874342
WACC: 0.05
Base cash flow: -7513248
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for PGIC.TO (Financial Services — Asset Management, Canada)
Report date: 2025-12-31 (annual)
Stock price: 5.212765957446808
Market cap: 27884848 (USD: 20353903.649635036)
P/E ratio: 3.2183145321831446
P/B ratio: 0.8596065558606141
Debt to equity: 1.5361000000000002
Current ratio: 1.64
Return on net tangible assets (%): 14.097889412044742
Buffett classification: The Gruesome
Rule of 40 score: -834.053775555795
Piotroski F-score: 2 (Weak)
Dividend yield (%): 7.514955792479128
Buyback yield (%): 9.44888421123902
Total shareholder yield (%): 16.963840003718147 (High Return)
Momentum (%): 1m 2.807328605200931, 3m 5.487287469750788, 6m 15.83924349881796, 12m 36.072201576346636, composite 17.894350040625444 (Strong Uptrend)
Lynch category: Asset Play (confidence: Medium)
Screener: long score 1, short score 4, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
Equity multiplier (leverage): 2.5543096003193364
ROE archetype: Standard Business
P/E z-score: 3.0209855430929498
Treasury beta 1y: 0.0036648232618091813 (R-squared: 0.00969463005100844)
Dividend increase streak (years): 0
Capital allocation category: Standard Allocator
Industry percentiles: P/E 20.23701002734731, P/B 35.824977210574296, ROIC , revenue growth 1y , 6m momentum 9.662716499544212
Sector percentiles: P/E 20.33109156751164, 6m momentum 16.114847387480598
Industry median P/E: 7.917582417582417; industry median ROIC: 1.6915626385800535
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.15
Base cash flow: 2643177.3722627736
DCF price per share: base 5.094435539984322, conservative 4.005194906872475, aggressive 6.580493123973438
Financial scorecard for PGP (Financial Services — Asset Management, United States)
Report date: 2025-12-31 (quarterly)
Stock price: 8.34
Market cap: 96641264 (USD: 96641264)
P/E ratio: 4.147619047619048
P/B ratio: 0.9776313131792557
Debt to equity: 0.16879999999999998
Current ratio: 0.59
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 3.1094378070220605
Total shareholder yield (%): 3.1094378070220605 (Low Return)
Momentum (%): 1m -0.5959475566150263, 3m -7.538802660753878, 6m -3.917050691244238, 12m 9.448818897637793, composite -0.4502888251192297 (Moderate Uptrend)
Lynch category: Asset Play (confidence: Medium)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.460160045777779 (Likely Safe)
Equity multiplier (leverage): 2.1857108076852847
ROE archetype: Standard Business
P/E z-score: 4.065171949563322
FCF z-score: 4.7172547047344215
Treasury beta 1y: -0.002594530422230017 (R-squared: 0.0068871962646606935)
Dividend increase streak (years): 0
Capital allocation category: Standard Allocator
Industry percentiles: P/E 23.062898814949865, P/B 60.43755697356426, ROIC , revenue growth 1y , 6m momentum 53.6918869644485
Sector percentiles: P/E 21.753750646663217, 6m momentum 47.77547853078117
Industry median P/E: 7.917582417582417; industry median ROIC: 1.6915626385800535
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.09042709403410948
Base cash flow: 17580000
DCF price per share: base 59.66999567162737, conservative 33.00254492172362, aggressive 107.74635492233438
Financial scorecard for PHARM.AS (Healthcare — Biotechnology, Netherlands)
Report date: 2026-03-31 (quarterly)
Stock price: 1.379310344827586
Market cap: 848915264 (USD: 975764671.2643678)
P/E ratio: 82.183908045977
P/B ratio: 3.7549850870017836
Debt to equity: 0.4321
Current ratio: 2.63
Interest coverage ratio: -1.962152133580705
Return on net tangible assets (%): -1.692372365407474
Buffett classification: The Gruesome
Analyst consensus upside (%): 44.7972027972028
Rule of 40 score: -35.624111707647316
Altman Z-score: 2.067301553065402 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Magic formula: return on capital % 10.055911658616221, earnings yield % 2.9204192144481658, rank 3515
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.2702410646086387
Total shareholder yield (%): 0.2702410646086387 (Low Return)
Momentum (%): 1m 11.111111111111097, 3m -19.850885368126754, 6m -26.3225530092097, 12m 33.22884012539183, composite -8.7558274214946 (Moderate Uptrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 3, short score 9, recommendation: Short
Revenue growth 1y (%): -3.139782171017813
Revenue deceleration: no
Accrual ratio: -0.013838890211235955
FCF conversion rate: -0.32879340111260313
Beneish M-score: -2.2155756153900565 (Likely Safe)
ROE (%): -1.8867786341401225
Net margin (%): -7.195605063011581
Asset turnover: 0.14473597215727027
Equity multiplier (leverage): 1.811661889166568
ROE archetype: Low Return
P/E z-score: 3.950141071068648
FCF z-score: 3.95014107106865
Treasury beta 1y: -0.12291958726381044 (R-squared: 0.004098891484934489)
Dividend increase streak (years): 0
ROIC (%): 6.3490055010852515 (pretax: 9.767700770900385)
Incremental ROIC 3y (%): 8.30363104979938 (pretax: 18.27081932891195)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 12.906137184115524, P/B 39.53068592057762, ROIC 7.039711191335741, revenue growth 1y 19.314079422382672, 6m momentum 49.0072202166065
Sector percentiles: P/E 32.700573065902574, 6m momentum 55.44412607449857
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.052839932075274335
Base cash flow: 15661176.470588237
DCF price per share: base 2.451190620908041, conservative 1.2498053940932647, aggressive 5.015046610191645
Financial scorecard for PHG (Healthcare — Medical Devices, Netherlands)
Report date: 2026-03-31 (quarterly)
Stock price: 26.17
Market cap: 25436786688 (USD: 25436786688)
P/E ratio: 23.131578947368425
P/B ratio: 1.952980283127036
Debt to equity: 0.7091
Current ratio: 1.32
Interest coverage ratio: 2.915662650602409
Return on net tangible assets (%): -45.6858407079646
Buffett classification: The Great
Analyst consensus upside (%): 26.128175957527482
Rule of 40 score: -25.29026370638971
Altman Z-score: 1.3045037060564741 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Magic formula: return on capital % 5.338627840282373, earnings yield % 0.9136412185239877, rank 1331
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.461869608214624
Total shareholder yield (%): -0.461869608214624 (Minimal or Negative)
Momentum (%): 1m -2.095024317246535, 3m -1.0211800302571845, 6m -7.526501766784449, 12m 5.227181342983517, composite -0.3562638559499461 (Flat)
Lynch category: Fast Grower (confidence: Medium)
Screener: long score 1, short score 6, recommendation: Neutral
Revenue growth 1y (%): 0.7914397694977371
Net income growth 1y (%): 110.10284331518454
Revenue deceleration: no
Accrual ratio: 0.004594852820986507
FCF conversion rate: 0.16556291390728478
Beneish M-score: -2.6256344769720674 (Likely Safe)
ROE (%): 1.3324177178855925
Net margin (%): 3.8668373879641478
Asset turnover: 0.1424039703647009
Equity multiplier (leverage): 2.41970483340107
ROE archetype: Low Return
P/E z-score: 1.4946390335394988
FCF z-score: 3.7113948201569498
Treasury beta 1y: -0.0021940728766651815 (R-squared: 0.001030161150716777)
Dividend increase streak (years): 2
ROIC (%): 6.893036938559208 (pretax: 9.052855179307759)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 18.694362017804153, P/B 31.15727002967359, ROIC 20.178041543026705, revenue growth 1y 42.433234421364986, 6m momentum 32.34421364985163
Sector percentiles: P/E 25.537249283667624, 6m momentum 37.67908309455588
Industry median P/E: 21.626420273203117; industry median ROIC: -5.9391058628332924
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.0769072403290687
Base cash flow: 2367058823.529412
DCF price per share: base 45.66000845637893, conservative 36.61343725383423, aggressive 57.38902279564925
Financial scorecard for PLAN.SW (Real Estate — Real Estate - Diversified, Switzerland)
Report date: 2025-12-31 (annual)
Stock price: 530.4878048780488
Market cap: 900449984 (USD: 1139810106.329114)
P/E ratio: 17.522061236119985
P/B ratio: 0.9409977411167514
Debt to equity: 0.4156
Current ratio: 0.04
Interest coverage ratio: 6.479534593808436
Return on net tangible assets (%): 7.696193149801764
Buffett classification: The Great
Rule of 40 score: 103.84279247199873
Piotroski F-score: 6 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -2.3008121348359056
Total shareholder yield (%): -2.3008121348359056 (Minimal or Negative)
Momentum (%): 1m -1.2195121951219337, 3m -5.611404087013834, 6m -0.8035017388613649, 12m 7.399955371122881, composite 0.7703249733999323 (Flat)
Lynch category: Asset Play (confidence: Medium)
Screener: long score 6, short score 1, recommendation: Neutral
Revenue deceleration: no
Accrual ratio: 0.029329856105073583
FCF conversion rate: 0.44544750671301253
Beneish M-score: -0.9389914967550578 (Strong Manipulation Signal)
ROE (%): 8.414854594132212
Net margin (%): 152.00450732440214
Asset turnover: 0.03479451634008002
Equity multiplier (leverage): 1.5910335799486774
ROE archetype: Standard Business
P/E z-score: 4.503895664414682
FCF z-score: 4.503895664414683
Treasury beta 1y: 0.009398863819596934 (R-squared: 0.0004963492513106754)
Dividend increase streak (years): 3
ROIC (%): 2.3975784532846225 (pretax: 2.798906141600275)
Incremental ROIC 3y (%): 2.934356008211544 (pretax: 3.205323088969445)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 52.702702702702695, P/B 43.24324324324324, ROIC 52.702702702702695, revenue growth 1y , 6m momentum 39.189189189189186
Sector percentiles: P/E 40.21739130434783, 6m momentum 33.307453416149066
Industry median P/E: 0.1786011340287656; industry median ROIC: 2.960519784941141
Sector median P/E: 4.332660990050401; sector median ROIC: 3.0025005588392872
WACC: 0.05
Base cash flow: 76762025.31645569
DCF price per share: base 4769.189461587237, conservative 2159.5056967603514, aggressive 10527.927596776717
Financial scorecard for PODDARMENT.NS (Basic Materials — Specialty Chemicals, India)
Report date: 2026-03-31 (annual)
Stock price: 2.724814203137903
Market cap: 2800827904 (USD: 29682364.391691394)
P/E ratio: 0.15378929547676046
P/B ratio: 0.6112642555779753
Debt to equity: 0.0174
Current ratio: 3.95
Interest coverage ratio: 12.51312690798081
Return on net tangible assets (%): -2.1031060303323015
Buffett classification: The Gruesome
Rule of 40 score: -1.8052210382284581
Altman Z-score: 4.176394499477418 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 1.5152662517889568
Buyback yield (%): 0
Debt paydown yield (%): 2.6381291232836097
Total shareholder yield (%): 4.1533953750725665 (Moderate Return)
Momentum (%): 1m 3.6354908510152266, 3m 0.8662489310105169, 6m -1.0573117432851982, 12m -20.27364721083856, composite -7.753826013086729 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 4, recommendation: Neutral
Revenue growth 1y (%): -7.781726048460202
Net income growth 1y (%): -41.362905749092334
Revenue CAGR 3y (%): -1.105577832005833
Net income CAGR 3y (%): -22.26692911864735
FCF CAGR 3y (%): 19.202169372637744
Revenue deceleration: yes
Revenue growth consistency score: 7.42557951498891
Accrual ratio: -0.01760955824512842
FCF conversion rate: 1.517927558030814
Beneish M-score: -2.92194562316881 (Likely Safe)
ROE (%): 1.352908427984065
Net margin (%): 4.722260106578373
Asset turnover: 0.2438216827043039
Equity multiplier (leverage): 1.1750224743199522
ROE archetype: Low Return
P/E z-score: 4.608331959890318
FCF z-score: 2.791983589580038
Treasury beta 1y: -0.029568090981133513 (R-squared: 0.0007303651688777379)
Dividend increase streak (years): 0
ROIC (%): 3.2090064276130743 (pretax: 4.35783829495624)
Incremental ROIC 3y (%): -41.960949883534795 (pretax: -56.392430489838866)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 29.069767441860467, P/B 18.13953488372093, ROIC 62.558139534883715, revenue growth 1y 48.13953488372093, 6m momentum 51.162790697674424
Sector percentiles: P/E 9.300388672959468, 6m momentum 25.180455302609662
Industry median P/E: 0.2375559102197765; industry median ROIC: 5.779832452013451
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.05
Base cash flow: -779164.9003815171
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for POLYMED.NS (Healthcare — Medical Instruments & Supplies, India)
Report date: 2026-03-31 (annual)
Stock price: 17.17588769611891
Market cap: 168861876224 (USD: 1789549345.3158119)
P/E ratio: 0.39531290521564116
P/B ratio: 3.8166089896528756
Debt to equity: 0.11230000000000001
Current ratio: 3.37
Interest coverage ratio: 17.86699798258131
Return on net tangible assets (%): 5.286665681322869
Buffett classification: The Gruesome
Analyst consensus upside (%): 12688.81475946604
Rule of 40 score: -1.501936458410225
Altman Z-score: 13.785189324847941 (Safe Zone)
Piotroski F-score: 3 (Weak)
Magic formula: return on capital % 2.6533000072541246, earnings yield % 0.0046529658615073145, rank 2874
Dividend yield (%): 0.20982237549581523
Buyback yield (%): 0
Debt paydown yield (%): -0.9164025783467151
Total shareholder yield (%): -0.7065802028508998 (Minimal or Negative)
Momentum (%): 1m -0.9751656116907197, 3m 14.299447820799777, 6m -1.092812738575643, 12m -28.18339905512207, composite -4.756512179419766 (Strong Downtrend)
Lynch category: Slow Grower (confidence: Low)
Screener: long score 5, short score 3, recommendation: Neutral
Revenue growth 1y (%): 1.805195696973949
Net income growth 1y (%): -11.292500131497096
Revenue CAGR 3y (%): 13.746912904262443
Net income CAGR 3y (%): 17.1501372422042
Revenue deceleration: yes
Revenue growth consistency score: 10.692823040462086
Accrual ratio: 0.10572560423291362
FCF conversion rate: -0.18719824589840808
Beneish M-score: -0.5195398184446619 (Strong Manipulation Signal)
ROE (%): 10.686726216310635
Net margin (%): 17.666469787216613
Asset turnover: 0.5040889234107556
Equity multiplier (leverage): 1.2000179814958034
ROE archetype: Standard Business
P/E z-score: 4.546149332480899
Treasury beta 1y: 0.0006469694746187597 (R-squared: 4.464750956303389e-05)
Dividend increase streak (years): 1
ROIC (%): 9.629024061987975 (pretax: 12.424472263915945)
Incremental ROIC 3y (%): 4.662260486901538 (pretax: 5.544544648315227)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 15.337423312883436, P/B 55.828220858895705, ROIC 31.901840490797547, revenue growth 1y 46.62576687116564, 6m momentum 33.74233128834356
Sector percentiles: P/E 9.527220630372494, 6m momentum 30.26504297994269
Industry median P/E: 15.690276110444179; industry median ROIC: 5.717819487534456
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05
Base cash flow: 14942782.958880883
DCF price per share: base 0.12331013578843543, conservative 0.06149037505015853, aggressive 0.25909499918861245
Financial scorecard for PRITI.NS (Consumer Cyclical — Furnishings, Fixtures & Appliances, India)
Report date: 2026-03-31 (annual)
Stock price: 0.3894508670520231
Market cap: 503821088 (USD: 5339350.233149639)
P/E ratio: 0.5002296339510693
P/B ratio: 0.5939611638052487
Debt to equity: 0
Current ratio: 7.85
Interest coverage ratio: -349.78378378378375
Return on net tangible assets (%): 1.6378834870191605
Buffett classification: The Gruesome
Rule of 40 score: -66.17320747870723
Altman Z-score: 5.637335036665843 (Safe Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.754935072294225
Total shareholder yield (%): 0.754935072294225 (Low Return)
Momentum (%): 1m -9.678524546755458, 3m -20.358059325802067, 6m -30.585708804198493, 12m -62.62102320229415, composite -36.51979819323625 (Strong Downtrend)
Lynch category: Asset Play (confidence: Medium)
Screener: long score 4, short score 6, recommendation: Neutral
Revenue growth 1y (%): -69.71702841922011
Net income growth 1y (%): -82.80916377700945
Revenue CAGR 3y (%): -35.34018086788564
Net income CAGR 3y (%): -52.051851211239054
Revenue deceleration: yes
Revenue growth consistency score: 44.01397085276538
Accrual ratio: -0.00013113718519131473
FCF conversion rate: 1.0119800332778703
Beneish M-score: -3.059336580298374 (Likely Safe)
ROE (%): 0.2401600882480924
Net margin (%): 2.872153535085684
Asset turnover: 0.07712247209106735
Equity multiplier (leverage): 1.0842070836832491
ROE archetype: Low Return
P/E z-score: 4.672591814362884
FCF z-score: 3.367750147429082
Treasury beta 1y: -0.018658160362099163 (R-squared: 0.00011066382151152331)
Dividend increase streak (years): 0
ROIC (%): -1.3005555482168023 (pretax: -1.827558256773206)
Incremental ROIC 3y (%): -24.477014882610543 (pretax: -32.99632426027042)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 31.28834355828221, P/B 25.766871165644172, ROIC 68.71165644171779, revenue growth 1y 60.73619631901841, 6m momentum 77.91411042944786
Sector percentiles: P/E 31.467315716272605, 6m momentum 75.34770514603616
Industry median P/E: 0.5336405520626155; industry median ROIC: 5.666341450255377
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.05
Base cash flow: 125254.34506146674
DCF price per share: base 0.0034144279560177184, conservative 0.0027332712088232194, aggressive 0.004451331759952374
Financial scorecard for PTL.NS (Real Estate — Real Estate Services, India)
Report date: 2026-03-31 (annual)
Stock price: 0.40524360033030554
Market cap: 5197121024 (USD: 55077586.095803306)
P/E ratio: 0.10683767143455725
P/B ratio: 0.552770269441044
Debt to equity: 0.0064
Current ratio: 0.25
Interest coverage ratio: 12.402182984143717
Return on net tangible assets (%): 5.729950046838876
Buffett classification: The Great
Rule of 40 score: 61.52260517753241
Altman Z-score: 1.8268049547462442 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Dividend yield (%): 8.278160120059578
Buyback yield (%): 0
Debt paydown yield (%): 1.8079604685577024
Total shareholder yield (%): 10.08612058861728 (High Return)
Momentum (%): 1m -6.990388523177036, 3m 0.44107249693193856, 6m 4.0496467926045385, 12m -7.519685503068136, composite 1.3072138552513797 (Moderate Downtrend)
Lynch category: Asset Play (confidence: Medium)
Screener: long score 3, short score 5, recommendation: Neutral
Revenue growth 1y (%): -9.347181008902062
Net income growth 1y (%): 37.15089636817559
Revenue deceleration: no
Beneish M-score: 122.37362039887617 (Strong Manipulation Signal)
ROE (%): 5.184301587649678
Net margin (%): 71.75708839295567
Asset turnover: 0.05748329874511709
Equity multiplier (leverage): 1.2568509181612295
ROE archetype: Standard Business
P/E z-score: 4.237882547135513
FCF z-score: 4.237882547135512
Treasury beta 1y: 0.0004423742812106276 (R-squared: 9.31914296909685e-05)
Dividend increase streak (years): 1
ROIC (%): 5.013190250969942 (pretax: 6.682226789680384)
Incremental ROIC 3y (%): 3.810721339807695 (pretax: -47.28180088094035)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 17.370892018779344, P/B 32.3943661971831, ROIC 34.50704225352113, revenue growth 1y 38.497652582159624, 6m momentum 19.014084507042252
Sector percentiles: P/E 10.170807453416149, 6m momentum 23.75776397515528
Industry median P/E: 0.9094611103569973; industry median ROIC: 3.7422962097312933
Sector median P/E: 4.332660990050401; sector median ROIC: 3.0025005588392872
WACC: 0.05
Base cash flow: 5116447.647308181
DCF price per share: base 0.01438418608803127, conservative 0.011427482281999322, aggressive 0.018885084649500228
Financial scorecard for PULM (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 1.65
Market cap: 6026270 (USD: 6026270)
P/B ratio: 1.3120154970760234
Debt to equity: 0
Current ratio: 4.96
Return on net tangible assets (%): -32.63714842662211
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: -90.4995227305794 (Distress Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 7.843137254901953, 3m 22.222222222222207, 6m -37.96992481203008, 12m -70.58823529411765, composite -29.491658439026867 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Accrual ratio: -0.024319629415170817
FCF conversion rate: 0.9104095563139932
Beneish M-score: -3.3588883473590823 (Likely Safe)
ROE (%): -31.67139575733009
Asset turnover: 0
Equity multiplier (leverage): 1.1667342251047155
ROE archetype: Low Return
Treasury beta 1y: 0.006429825581377864 (R-squared: 0.0010641956354920956)
Dividend increase streak (years): 0
Incremental ROIC 3y (%): 321.6495271867612 (pretax: 407.1513002364066)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 15.072202166064983, ROIC , revenue growth 1y , 6m momentum 59.65703971119134
Sector percentiles: P/E , 6m momentum 64.32664756446992
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.15
Base cash flow: -5162000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for QH (Technology — Software - Application, China)
Report date: 2025-12-31 (annual)
Stock price: 5.38
Market cap: 17520578 (USD: 17520578)
P/B ratio: 0.07041748034919511
Debt to equity: 0.3289
Current ratio: 1.03
Interest coverage ratio: -43.4976167778837
Return on net tangible assets (%): -55.26820275744237
Buffett classification: The Gruesome
Rule of 40 score: -15.513201044078167
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 4.824591255826129
Total shareholder yield (%): 4.824591255826129 (Moderate Return)
Momentum (%): 1m -14.057507987220447, 3m 4383.333333333334, 6m 504.49438202247194, 12m -96.21659634317862, composite 1597.409988569141 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 17, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Beneish M-score: -2.4291078745929866 (Likely Safe)
ROE (%): -37.77727289000324
Net margin (%): -5.917264243157975
Asset turnover: 3.099722619340985
Equity multiplier (leverage): 2.059618609529374
ROE archetype: Low Return
Treasury beta 1y: -0.040475405460542915 (R-squared: 5.3252333608397964e-05)
Dividend increase streak (years): 0
ROIC (%): -33.83082200458938 (pretax: -42.82382532226504)
Incremental ROIC 3y (%): -1080.0098344102967 (pretax: -1398.7440724970832)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 5.121293800539084, ROIC 64.55525606469003, revenue growth 1y , 6m momentum 0
Sector percentiles: P/E , 6m momentum 0.1668335001668335
Industry median P/E: 2.1394954536591486; industry median ROIC: 6.21806735836372
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.06853203339825462
Base cash flow: -19316000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for QRF.BR (Real Estate — REIT - Retail, Belgium)
Report date: 2025-12-31 (annual)
Stock price: 11.666666666666668
Market cap: 107965688 (USD: 127018456.47058824)
P/E ratio: 5.6448494890914125
Debt to equity: 0.7698999999999999
Current ratio: 0.08
Buffett classification: The Gruesome
Analyst consensus upside (%): -2.6908023483366144
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -5.581395348837199, 3m -7.951070336391437, 6m -3.618315722062119, 12m 2.869986168741361, composite -0.872805161882893 (Flat)
Lynch category:  (confidence: High)
Screener: long score 1, short score 2, recommendation: Neutral
Revenue deceleration: no
Revenue growth consistency score: 16.548182062486802
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: 0.057603407838642755 (R-squared: 0.006142185514120605)
Dividend increase streak (years): 0
Capital allocation category: Standard Allocator
Industry percentiles: P/E 20.33898305084746, P/B , ROIC , revenue growth 1y , 6m momentum 86.4406779661017
Sector percentiles: P/E 28.804347826086957, 6m momentum 40.91614906832298
Industry median P/E: 13.362381989832972; industry median ROIC: 3.8218423418177516
Sector median P/E: 4.332660990050401; sector median ROIC: 3.0025005588392872
WACC: 0.07055
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for QS51.DE (Healthcare — Medical Instruments & Supplies, Switzerland)
Report date: 2025-12-31 (annual)
Stock price: 117.04545454545455
Market cap: 16423432192 (USD: 20789154673.41772)
P/E ratio: 48.64705882352941
P/B ratio: 6.7938271127284855
Debt to equity: 0.1935
Current ratio: 2.21
Interest coverage ratio: 35.9968541093197
Return on net tangible assets (%): 26.371306215501455
Buffett classification: The Good
Rule of 40 score: 28.58113592020279
Altman Z-score: 8.719369338790449 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Magic formula: return on capital % 33.63512103352489, earnings yield % 4.250407198110297, rank 1218
Dividend yield (%): 0.9214882628109797
Buyback yield (%): 0.14953634363932106
Debt paydown yield (%): -0.3387092121029031
Total shareholder yield (%): 0.7323153943473977 (Low Return)
Momentum (%): 1m -9.649122807017534, 3m 9.412055335968375, 6m -3.6896066179706066, 12m -14.100642062134025, composite 0.26517483129608443 (Moderate Downtrend)
Lynch category: Stalwart (confidence: Medium)
Screener: long score 12, short score 1, recommendation: Strong Long (L/S Compounder)
Revenue growth 1y (%): 18.54184434307795
Net income growth 1y (%): 4.3063837993162934
Revenue CAGR 3y (%): 9.34519155656821
Net income CAGR 3y (%): -1.4602961052485819
FCF CAGR 3y (%): 14.133605763575542
Revenue deceleration: no
Revenue growth consistency score: 8.152696100781279
Beneish M-score: -2.628880810007585 (Likely Safe)
Equity multiplier (leverage): 1.669039407376474
ROE archetype: Standard Business
P/E z-score: 4.309275211774247
FCF z-score: 4.309275211774254
Treasury beta 1y: -0.04296460603653959 (R-squared: 0.0013515407192745924)
Dividend increase streak (years): 0
ROIC (%): 20.634341666517155 (pretax: 26.22784858484034)
Incremental ROIC 3y (%): 6.242649331706166 (pretax: 17.965959936321326)
Capital allocation category: Fading Compounder
Industry percentiles: P/E 49.079754601226995, P/B 65.03067484662577, ROIC 10.429447852760736, revenue growth 1y 15.337423312883436, 6m momentum 41.717791411042946
Sector percentiles: P/E 31.088825214899714, 6m momentum 33.739255014326645
Industry median P/E: 15.690276110444179; industry median ROIC: 5.717819487534456
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.12038800787349228
Base cash flow: 430045569.62025315
DCF price per share: base 46.93129939018259, conservative 33.35295682398879, aggressive 66.90991937401277
Financial scorecard for RCEL (Healthcare — Medical Devices, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 4.61
Market cap: 141880528 (USD: 141880528)
Debt to equity: -2.0771820771820773
Current ratio: 0.48
Interest coverage ratio: -6.18188202247191
Buffett classification: The Gruesome
Analyst consensus upside (%): 144.5945945945946
Rule of 40 score: -48.86528420072563
Altman Z-score: -11.246947931157388 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -1.4603836264268766
Total shareholder yield (%): -1.4603836264268766 (Minimal or Negative)
Momentum (%): 1m 16.708860759493675, 3m 3.363228699551578, 6m 3.828828828828827, 12m -22.90969899665552, composite -8.918143588644659 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 1, short score 9, recommendation: Short
Revenue growth 1y (%): 3.9807713081992047
Revenue deceleration: no
Accrual ratio: -0.009579750963533947
FCF conversion rate: 0.9512769767222693
Beneish M-score: -2.286205379020682 (Likely Safe)
Net margin (%): -55.11921458625526
Asset turnover: 0.35671138452416246
ROE archetype: Standard Business
Treasury beta 1y: 0.0055019877710532185 (R-squared: 0.0006761208432918852)
Dividend increase streak (years): 0
ROIC (%): -299.6687773120485 (pretax: -379.32756621778293)
Incremental ROIC 3y (%): -242.4527261588728 (pretax: -306.9021850112314)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B , ROIC 66.17210682492582, revenue growth 1y 36.20178041543027, 6m momentum 16.913946587537094
Sector percentiles: P/E , 6m momentum 24.24785100286533
Industry median P/E: 21.626420273203117; industry median ROIC: -5.9391058628332924
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.13003657602300386
Base cash flow: -47245000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for RENE.LS (Utilities — Utilities - Diversified, Portugal)
Report date: 2026-03-31 (quarterly)
Stock price: 4.2298850574712645
Market cap: 2440980480 (USD: 2805724689.6551723)
P/E ratio: 14.427269124058661
P/B ratio: 1.5458244824433576
Debt to equity: 1.5406
Current ratio: 0.36
Interest coverage ratio: 4.721504339440695
Return on net tangible assets (%): -3.620408779335148
Buffett classification: The Great
Analyst consensus upside (%): -12.760989010989007
Rule of 40 score: 1.0263184600533606
Altman Z-score: 0.4278465507498914 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 8.409048135010561
Total shareholder yield (%): 8.409048135010561 (Moderate Return)
Momentum (%): 1m 5.444126074498557, 3m -4.77222121923331, 6m 10.905522848331946, 12m 23.553343603112527, composite 7.76917746104581 (Moderate Uptrend)
Lynch category: Fast Grower (confidence: Medium)
Screener: long score 2, short score 4, recommendation: Neutral
Revenue growth 1y (%): 4.629562581162183
Net income growth 1y (%): 165.12561070430655
Revenue deceleration: no
Accrual ratio: -0.005990288744187839
FCF conversion rate: 1.9050288586341164
Beneish M-score: -2.1639033484076555 (Likely Safe)
ROE (%): 2.3196739048414323
Net margin (%): 16.707345769296428
Asset turnover: 0.03961666091630171
Equity multiplier (leverage): 3.5046254298491544
ROE archetype: Low Return
P/E z-score: 5.977630124481056
FCF z-score: 5.030134930217257
Treasury beta 1y: -0.05540603115788726 (R-squared: 0.007305999157759904)
Dividend increase streak (years): 0
ROIC (%): 5.505531027464203 (pretax: 5.985476855683253)
Incremental ROIC 3y (%): 4.0581856984111955 (pretax: 1.8702802250044892)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 31.25, P/B 65.625, ROIC 40.625, revenue growth 1y 43.75, 6m momentum 40.625
Sector percentiles: P/E 36.49193548387097, 6m momentum 23.991935483870968
Industry median P/E: 16.556605652226406; industry median ROIC: 5.0786351512921915
Sector median P/E: 8.380462724935732; sector median ROIC: 4.834251840514727
WACC: 0.05
Base cash flow: 476662352.9411764
DCF price per share: base 66.78476040916341, conservative 31.205537673639885, aggressive 142.56747640077313
Financial scorecard for RI.PA (Consumer Defensive — Beverages - Wineries & Distilleries, France)
Report date: 2025-12-31 (quarterly)
Stock price: 73.79310344827587
Market cap: 16166365184 (USD: 19019253157.64706)
P/E ratio: 15.357142857142858
P/B ratio: 1.113648634654244
Debt to equity: 0.8229000000000001
Current ratio: 2.34
Buffett classification: The Gruesome
Analyst consensus upside (%): 0.5813953488372093
Rule of 40 score: 0
Piotroski F-score: 2 (Weak)
Magic formula: return on capital % 29.078505042515328, earnings yield % 12.176484462389151, rank 510
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -6.26609623418983
Total shareholder yield (%): -6.26609623418983 (Minimal or Negative)
Momentum (%): 1m 1.8078020932445482, 3m -2.6953864374160466, 6m -14.861726636011205, 12m -31.079949531881674, composite -16.620292195194647 (Strong Downtrend)
Lynch category:  (confidence: Medium)
Screener: long score 1, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.488278599007528 (Likely Safe)
Equity multiplier (leverage): 2.2822775148832237
ROE archetype: Standard Business
P/E z-score: 6.389236286457163
FCF z-score: 6.389236286457161
Treasury beta 1y: -0.042854956636005886 (R-squared: 0.0017480442911658525)
Dividend increase streak (years): 0
ROIC (%): 8.119215640154726 (pretax: 10.89824353368413)
Incremental ROIC 3y (%): 3.7744992708256286 (pretax: 5.4226418117497115)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 40, P/B 43.333333333333336, ROIC 31.666666666666664, revenue growth 1y , 6m momentum 56.666666666666664
Sector percentiles: P/E 49.094858797972485, 6m momentum 56.62563359884142
Industry median P/E: 8.540172771804777; industry median ROIC: 4.851856938633267
Sector median P/E: 1.0302878025850322; sector median ROIC: 7.163828537874342
WACC: 0.05485713229682856
Base cash flow: 2451764705.882353
DCF price per share: base 362.7909367560336, conservative 246.58225417172005, aggressive 543.1123490829085